Literature DB >> 23840067

Saturated and unsaturated fat induce hepatic insulin resistance independently of TLR-4 signaling and ceramide synthesis in vivo.

Thomas Galbo1, Rachel J Perry, Michael J Jurczak, João-Paulo G Camporez, Tiago C Alves, Mario Kahn, Blas A Guigni, Julie Serr, Dongyan Zhang, Sanjay Bhanot, Varman T Samuel, Gerald I Shulman.   

Abstract

Hepatic insulin resistance is a principal component of type 2 diabetes, but the cellular and molecular mechanisms responsible for its pathogenesis remain unknown. Recent studies have suggested that saturated fatty acids induce hepatic insulin resistance through activation of the toll-like receptor 4 (TLR-4) receptor in the liver, which in turn transcriptionally activates hepatic ceramide synthesis leading to inhibition of insulin signaling. In this study, we demonstrate that TLR-4 receptor signaling is not directly required for saturated or unsaturated fat-induced hepatic insulin resistance in both TLR-4 antisense oligonucleotide treated and TLR-4 knockout mice, and that ceramide accumulation is not dependent on TLR-4 signaling or a primary event in hepatic steatosis and impairment of insulin signaling. Further, we show that both saturated and unsaturated fats lead to hepatic accumulation of diacylglycerols, activation of PKCε, and impairment of insulin-stimulated IRS-2 signaling. These data demonstrate that saturated fat-induced insulin resistance is independent of TLR-4 activation and ceramides.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23840067      PMCID: PMC3732992          DOI: 10.1073/pnas.1311176110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-kappaB pathway in rat liver.

Authors:  Guenther Boden; Pengxiang She; Maria Mozzoli; Peter Cheung; Kiranmai Gumireddy; Prekumar Reddy; Xiaqin Xiang; Zhijan Luo; Neil Ruderman
Journal:  Diabetes       Date:  2005-12       Impact factor: 9.461

2.  Saturated fatty acids do not directly stimulate Toll-like receptor signaling.

Authors:  Clett Erridge; Nilesh J Samani
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-08-06       Impact factor: 8.311

3.  Prevention of hepatic steatosis and hepatic insulin resistance in mitochondrial acyl-CoA:glycerol-sn-3-phosphate acyltransferase 1 knockout mice.

Authors:  Susanne Neschen; Katsutaro Morino; Linda E Hammond; Dongyan Zhang; Zhen-Xiang Liu; Anthony J Romanelli; Gary W Cline; Rebecca L Pongratz; Xian-Man Zhang; Cheol S Choi; Rosalind A Coleman; Gerald I Shulman
Journal:  Cell Metab       Date:  2005-07       Impact factor: 27.287

4.  Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance.

Authors:  William L Holland; Joseph T Brozinick; Li-Ping Wang; Eric D Hawkins; Katherine M Sargent; Yanqi Liu; Krishna Narra; Kyle L Hoehn; Trina A Knotts; Angela Siesky; Don H Nelson; Sotirios K Karathanasis; Greg K Fontenot; Morris J Birnbaum; Scott A Summers
Journal:  Cell Metab       Date:  2007-03       Impact factor: 27.287

5.  Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease.

Authors:  Varman T Samuel; Zhen-Xiang Liu; Amy Wang; Sara A Beddow; John G Geisler; Mario Kahn; Xian-man Zhang; Brett P Monia; Sanjay Bhanot; Gerald I Shulman
Journal:  J Clin Invest       Date:  2007-02-22       Impact factor: 14.808

Review 6.  Recent advances in nonalcoholic fatty liver disease.

Authors:  Onpan Cheung; Arun J Sanyal
Journal:  Curr Opin Gastroenterol       Date:  2010-05       Impact factor: 3.287

7.  Tlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat.

Authors:  Jeremy E Davis; Nicholas K Gabler; Jennifer Walker-Daniels; Michael E Spurlock
Journal:  Obesity (Silver Spring)       Date:  2008-04-10       Impact factor: 5.002

Review 8.  Metabolic syndrome pandemic.

Authors:  Scott M Grundy
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-01-03       Impact factor: 8.311

Review 9.  Lipid mediators of insulin resistance.

Authors:  William L Holland; Trina A Knotts; Jose A Chavez; Li-Ping Wang; Kyle L Hoehn; Scott A Summers
Journal:  Nutr Rev       Date:  2007-06       Impact factor: 7.110

10.  SGLT2 deletion improves glucose homeostasis and preserves pancreatic beta-cell function.

Authors:  Michael J Jurczak; Hui-Young Lee; Andreas L Birkenfeld; Francois R Jornayvaz; David W Frederick; Rebecca L Pongratz; Xiaoxian Zhao; Gilbert W Moeckel; Varman T Samuel; Jean M Whaley; Gerald I Shulman; Richard G Kibbey
Journal:  Diabetes       Date:  2011-03       Impact factor: 9.461

View more
  35 in total

1.  Emerging Pharmacological Targets for the Treatment of Nonalcoholic Fatty Liver Disease, Insulin Resistance, and Type 2 Diabetes.

Authors:  Leigh Goedeke; Rachel J Perry; Gerald I Shulman
Journal:  Annu Rev Pharmacol Toxicol       Date:  2019-01-06       Impact factor: 13.820

Review 2.  Mechanisms of Insulin Action and Insulin Resistance.

Authors:  Max C Petersen; Gerald I Shulman
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

3.  Anti-inflammatory effects of oestrogen mediate the sexual dimorphic response to lipid-induced insulin resistance.

Authors:  João Paulo Camporez; Kun Lyu; Emily L Goldberg; Dongyan Zhang; Gary W Cline; Michael J Jurczak; Vishwa Deep Dixit; Kitt Falk Petersen; Gerald I Shulman
Journal:  J Physiol       Date:  2019-07-04       Impact factor: 5.182

Review 4.  Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus.

Authors:  Giovanni Targher; Amedeo Lonardo; Christopher D Byrne
Journal:  Nat Rev Endocrinol       Date:  2017-12-29       Impact factor: 43.330

5.  Elevated circulating stearic acid leads to a major lipotoxic effect on mouse pancreatic beta cells in hyperlipidaemia via a miR-34a-5p-mediated PERK/p53-dependent pathway.

Authors:  Huimin Lu; Liuyi Hao; Songtao Li; Song Lin; Lin Lv; Yang Chen; Hongli Cui; Tianqi Zi; Xia Chu; Lixin Na; Changhao Sun
Journal:  Diabetologia       Date:  2016-03-11       Impact factor: 10.122

6.  The glucocorticoid-Angptl4-ceramide axis induces insulin resistance through PP2A and PKCζ.

Authors:  Tzu-Chieh Chen; Daniel I Benjamin; Taiyi Kuo; Rebecca A Lee; Mei-Lan Li; Darryl J Mar; Damian E Costello; Daniel K Nomura; Jen-Chywan Wang
Journal:  Sci Signal       Date:  2017-07-25       Impact factor: 8.192

Review 7.  Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms.

Authors:  Shaodong Guo
Journal:  J Endocrinol       Date:  2014-01-08       Impact factor: 4.286

Review 8.  Adipose tissue inflammation in glucose metabolism.

Authors:  H L Kammoun; M J Kraakman; M A Febbraio
Journal:  Rev Endocr Metab Disord       Date:  2014-03       Impact factor: 6.514

9.  Obesity superimposed on aging magnifies inflammation and delays the resolving response after myocardial infarction.

Authors:  Elizabeth F Lopez; Janusz H Kabarowski; Kevin A Ingle; Vasundhara Kain; Stephen Barnes; David K Crossman; Merry L Lindsey; Ganesh V Halade
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-12-05       Impact factor: 4.733

Review 10.  Lipid signaling and lipotoxicity in metaflammation: indications for metabolic disease pathogenesis and treatment.

Authors:  Meric Erikci Ertunc; Gökhan S Hotamisligil
Journal:  J Lipid Res       Date:  2016-06-21       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.